These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 28273466)

  • 1. Precision Metabolism: Hitting the Mark.
    Mott R; Granger A; Helenius T; Emambokus N
    Cell Metab; 2017 Mar; 25(3):483. PubMed ID: 28273466
    [No Abstract]   [Full Text] [Related]  

  • 2. Point-of-Care Testing and Personalized Medicine for Metabolic Disorders.
    Guest FL; Guest PC
    Methods Mol Biol; 2018; 1735():105-114. PubMed ID: 29380309
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Precision in personalized prediction-based medicine.
    Kyrochristos ID; Ziogas DE; Roukos DH
    Per Med; 2018 Nov; 15(6):467-470. PubMed ID: 30387685
    [No Abstract]   [Full Text] [Related]  

  • 4. A thematic review series: systems biology approaches to metabolic and cardiovascular disorders.
    Lusis AJ
    J Lipid Res; 2006 Sep; 47(9):1887-90. PubMed ID: 16924129
    [No Abstract]   [Full Text] [Related]  

  • 5. Sex differences in lipid metabolism and metabolic disease risk.
    Sugiyama MG; Agellon LB
    Biochem Cell Biol; 2012 Apr; 90(2):124-41. PubMed ID: 22221155
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Genetic information and prevention].
    Tönnies H; Schaade L
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2015 Feb; 58(2):111-2. PubMed ID: 25585840
    [No Abstract]   [Full Text] [Related]  

  • 7. Metabolism shaping chromatin shaping metabolism.
    Pospisilik JA
    Cell Mol Life Sci; 2013 May; 70(9):1493-4. PubMed ID: 23475108
    [No Abstract]   [Full Text] [Related]  

  • 8. Mechanisms of disease: The human N-glycome.
    Lauc G; Pezer M; Rudan I; Campbell H
    Biochim Biophys Acta; 2016 Aug; 1860(8):1574-82. PubMed ID: 26500099
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MicroRNA in cardiometabolic health and disease: The perspectives of sex, gender and personalised medicine.
    Ministrini S; Padro T
    Eur J Clin Invest; 2024 Jul; 54(7):e14223. PubMed ID: 38623918
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cellotype-phenotype associations using 'organoid villages'.
    Kimura M; Takebe T
    Trends Endocrinol Metab; 2024 Jun; 35(6):462-465. PubMed ID: 38575442
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rare diseases and omics-driven personalized medicine.
    Šimić G
    Croat Med J; 2019 Dec; 60(6):485-487. PubMed ID: 31894912
    [No Abstract]   [Full Text] [Related]  

  • 12. Five critical elements to ensure the precision medicine.
    Chen C; He M; Zhu Y; Shi L; Wang X
    Cancer Metastasis Rev; 2015 Jun; 34(2):313-8. PubMed ID: 25920354
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Networking metabolites and diseases.
    Braun P; Rietman E; Vidal M
    Proc Natl Acad Sci U S A; 2008 Jul; 105(29):9849-50. PubMed ID: 18632571
    [No Abstract]   [Full Text] [Related]  

  • 14. Systems medicine and metabolic modelling.
    Mardinoglu A; Nielsen J
    J Intern Med; 2012 Feb; 271(2):142-54. PubMed ID: 22142312
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The computable cell: A step toward personalized medicine.
    Gough NR
    Sci Signal; 2015 Dec; 8(408):eg6. PubMed ID: 26696628
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bringing Precision Medicine to Community Oncologists.
    Cancer Discov; 2017 Jan; 7(1):6-7. PubMed ID: 27864232
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Small But Mighty: The Use of Real-World Evidence to Inform Precision Medicine.
    Miksad RA; Samant MK; Sarkar S; Abernethy AP
    Clin Pharmacol Ther; 2019 Jul; 106(1):87-90. PubMed ID: 31112289
    [No Abstract]   [Full Text] [Related]  

  • 18. The implications of human metabolic network topology for disease comorbidity.
    Lee DS; Park J; Kay KA; Christakis NA; Oltvai ZN; Barabási AL
    Proc Natl Acad Sci U S A; 2008 Jul; 105(29):9880-5. PubMed ID: 18599447
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Obesity in Istanbul: results from outpatient clinic records over a period of 10 years.
    Yilmaz MT; Arioglu E; Korugan U; Satman I; Buyukdevrim S; Biyal F
    Diabetes Res Clin Pract; 1990; 10 Suppl 1():S49-60. PubMed ID: 2286151
    [No Abstract]   [Full Text] [Related]  

  • 20. Fangjiomics: revealing adaptive omics pharmacological mechanisms of the myriad combination therapies to achieve personalized medicine.
    Duan DD; Wang Z; Zhang BL; Wang YY
    Acta Pharmacol Sin; 2015 Jun; 36(6):651-3. PubMed ID: 26036241
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.